Project Grants in Clinical and Translational Medicine support Danish researchers pursuing clinical and translational research of high international quality to advance patient care and human health.
Funder: Novo Nordisk Foundation
Due Dates (Anticipated): August 2027 (Application deadline)
Funding Amounts: Up to DKK 4.5 million over 1–3 years under the 2026 guidelines; DKK 76 million total
Summary: Supports high-level Danish clinical and translational research with clear relevance to patients and human health.
Key Information: Only independent principal investigators at Danish research institutions may apply; their own salary must be secured separately.
The Novo Nordisk Foundation’s Project Grants in Clinical and Translational Medicine promote Danish clinical or translational research of high international quality. Supported research involves patients or humans, clinical practice, diagnostic or therapeutic methods, and may also involve established animal models. Areas include disease mechanisms, treatment methods, disease trajectories, epidemiology, diagnostics, public health, family medicine, intervention studies, register-based research, proof-of-concept studies, pilot projects, initial clinical trials, and implementation of clinical solutions.
The programme supports innovative medical research with clear relevance to patients and human health, alongside the Foundation’s ambition to reduce health inequity in Denmark and globally. A strategic theme focuses on interactions between infectious and cardiometabolic diseases, including their dual burden and effects on disease risk, severity, and prognosis.